- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00546026
Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?
17. oktober 2007 opdateret af: Mount Sinai Hospital, Canada
Women whose pregnancies are at judged to be at risk of a poor outcome from an early delivery due to medical problems such as diabetes or high blood pressure, are often very anxious during pregnancy, at least until they know they have passed the risk period of premature birth (after 8 months).
Anxiety itself can have a significant effect on the developing baby, on the newborn child and the mother-infant bonding process.
We will use a combination of pregnancy blood tests and an ultrasound assessment to check on placental function, since placental damage is the greatest cause of poor outcome.
Most women tested this way will have normal results, and so may feel reassured and do better in pregnancy than untested women.
The benefits may extend after birth to mother-infant bonding, breastfeeding success and a reduced risk of postnatal depression.
We will randomly select an equal number of women for testing and no testing (like tossing a coin, known as a randomized control trial) to be confident that any benefits observed are genuine.
The potential benefits of our research would be substantial for the mental health of many pregnant women, for their newborn and for their children as they grow up.
The tests are easy to do and would add very little in terms of a woman's and in terms of the total costs of prenatal care.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Women whose pregnancies are considered "high-risk" for medical reasons such (e.g.
preeclampsia, coagulation problems), often develop anxiety because of the possibility of a poor outcome.
Such anxiety can affect fetal development, neonatal wellbeing, child development and maternal mental health but it often goes unrecognized.
Also, women are often reluctant to use medications during pregnancy, especially if they perceive there may be the slightest risk to the fetus.
By assessing placental function at mid-pregnancy in this population, we can provide an accurate estimate of which women will develop severe complications later in the pregnancy.
We propose to perform a pilot randomized control trial formally incorporating placental assessment (Doppler ultrasound of the uterine artery and reassessment of diagnostic tests done earlier in pregnancy), with one group of "high-risk" women receiving the intervention (followed by feedback).
Measures of pregnancy outcome and anxiety will be compared with a control group receiving standard "high-risk" pregnancy care.
Levels of anxiety will be measured throughout the pregnancy using standardized scales.
We hypothesize that placental function testing will reduce the burden of anxiety for the majority of women who test negative in the placental assessment arm and that these women will have improved outcomes and measures of anxiety during and following pregnancy in comparison with untested women who perceive themselves to be at risk of pregnancy complications throughout pregnancy.
We also anticipate that the outcome of the pregnancy in women in the "tested" group will be more favorable (e.g.
reduced admissions of neonate to NICU).
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
160
Fase
- Fase 1
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X5
- Mount Sinai Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
N/A
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
- Patient of maternal/fetal medicine unit Mount Sinai Hospital
- Over 18 years of age
- Able to understand the nature of the study
- Able to provide consent to participation
- Singleton pregnancy
- Normal karyotype
- No major anatomical malformations at the 19 week ultrasound
- Fluent in English
Exclusion Criteria:
- Currently suffering from a major psychiatric illness or current use of psychotropic medications
- Current illegal substance or alcohol abuse
- Presence of a significant fetal structural abnormality on the 19 week ultrasound
- Abnormal karyotype
- Multifetal pregnancy
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Active group
Receive assessment of placental function
|
Formal assessment of placental function in mid-gestation by placental morphology and uterine artery Doppler at 20-22 weeks and re-interpretation of prior biochemical tests for Down's syndrome and spina bifida.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Primary outcome measure is STAI - The State Trait Anxiety Inventory
Tidsramme: Cross-sectional
|
Cross-sectional
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Women who undergo the placental function assessment will deliver at a later gestation age, have less complications and stillbirths than untested women. Neonates will have higher APGAR scores at 1 and 5 minutes and less likely to be admitted to the NICU.
Tidsramme: Cross-sectional
|
Cross-sectional
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Eileen P. Sloan, MD, Mount Sinai Hospital, Canada
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Datoer for studieregistrering
Først indsendt
16. oktober 2007
Først indsendt, der opfyldte QC-kriterier
17. oktober 2007
Først opslået (Skøn)
18. oktober 2007
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
18. oktober 2007
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
17. oktober 2007
Sidst verificeret
1. oktober 2007
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- Sloan01
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .